Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Recruiting · NCT06274801 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-07-29 | NCT06274801 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gossamer Bio USA, Inc. | 1 |
120 results · Page 1 of 5
Research sites
Swipe the table sideways for more columns.